These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Antisense therapy of cancer.
    Author: Narayanan R.
    Journal: In Vivo; 1994; 8(5):787-93. PubMed ID: 7727726.
    Abstract:
    Binding sites for the NF-kappa B transcription factor complex, composed of two subunits, p50 (NFKB1) and p65 (rel A), are present in many cell adhesion molecules, cytokines, and growth-factor receptors. Antisense techniques were used to establish the role of NF-kappa B in cell growth. Surprisingly, antisense phosphorothioate oligomers to the rel A subunit of NF-kappa B caused a pronounced block of cellular adhesion. Since adhesion plays an important role in diseases including cancer and inflammation, this chance observation was extended to various in vitro and in vivo models. Our results establish the in vivo efficacy of phosphorothioate oligomers.
    [Abstract] [Full Text] [Related] [New Search]